ADOS

CAS No. 82692-96-4

ADOS( —— )

Catalog No. M24817 CAS No. 82692-96-4

ADOS (82692-96-4) is a biochemical reagent/chromogenic reagent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 29 In Stock
25MG 46 In Stock
50MG 63 In Stock
100MG 96 In Stock
200MG 129 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ADOS
  • Note
    Research use only, not for human use.
  • Brief Description
    ADOS (82692-96-4) is a biochemical reagent/chromogenic reagent.
  • Description
    ADOS (82692-96-4) is a biochemical reagent/chromogenic reagent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    82692-96-4
  • Formula Weight
    311.33
  • Molecular Formula
    C12H18NNaO5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S(CC(O)CN(CC)C1=CC=CC(OC)=C1)([O-])=O.[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Deoxyvasicinone

    Deoxyvasicinone derivatives can be considered as promising lead molecules for the development of more potent inhibitors of NEDD8-activating enzyme.

  • 3,4,5-Trimethoxycinn...

    3,4,5-Trimethoxycinnamic acid is a phenylpropanoid isolated from the roots of?Polygala tenuifolia?WILLD, with anti-stress effect, prolonging the sleeping time in?animals. 3,4,5-Trimethoxycinnamic acid increases expression of GAD65 and?γ-subunit of GABAA receptor, but shows no effect on the amounts of α-, β-subunits.

  • FR054

    FR054 is an inhibitor of the Hexosamine Biosynthetic Pathway (HBP) enzyme PGM3, with a remarkable anti-breast cancer effect. FR054 induces in different breast cancer cells a dramatic decrease in cell proliferation and survival.